Martin A Lewis

Title: Martin A Lewis: Innovator in Biopharmaceuticals

Introduction

Martin A Lewis is a distinguished inventor based in Madison, CT (US). He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on polynucleotides and their applications in medicine. With a total of 2 patents, Lewis has established himself as a key figure in the development of novel therapeutic methods.

Latest Patents

Lewis's latest patents include the invention of polynucleotides encoding a novel human P2X7 splice variant, HBMYP2X7v. This invention provides novel polynucleotides that encode HBMYP2X7v polypeptides, fragments, and homologues. Additionally, the patent outlines vectors, host cells, antibodies, and both recombinant and synthetic methods for producing these polypeptides. The invention also encompasses diagnostic and therapeutic methods for utilizing these novel HBMYP2X7v polypeptides in the diagnosis, treatment, and prevention of various diseases and disorders. Furthermore, it includes screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides.

Career Highlights

Martin A Lewis is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and innovations. His work has been instrumental in the development of new therapeutic strategies that leverage the unique properties of the HBMYP2X7v polypeptides.

Collaborations

Throughout his career, Lewis has collaborated with notable colleagues, including Diana L Franco and Chandra S Ramanathan. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Martin A Lewis is a prominent inventor whose work in biopharmaceuticals has the potential to impact the diagnosis and treatment of various diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.